Shantou University Medical College, Shantou, Guangdong Province, China.
Department of Neurology, Guangdong Neuroscience Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong Province, China.
CNS Neurosci Ther. 2024 Aug;30(8):e14918. doi: 10.1111/cns.14918.
Rare studies have investigated the association between heterogeneity of motor progression and risk of early cognitive impairment in Parkinson's disease (PD). In this study, we aim to identify distinct trajectories of motor progression longitudinally and investigate their impact on predicting mild cognitive impairment (MCI).
A 5-year cohort including 415 PD patients at baseline was collected from the Parkinson's Progression Markers Initiative. The severity of motor symptoms was evaluated using the Movement Disorder Society Unified Parkinson's Disease Rating Scale part III. The latent class trajectory model and nonlinear mixed-effects model were used to analyze and delineate the longitudinal changes in motor symptoms. Propensity score matching (PSM) was used to minimize the impact of potential confounders. Cox proportional hazard models were applied to calculate hazard ratios for MCI, and a Kaplan-Meier curve was generated using the occurrence of MCI during the follow-up as the time-to-event.
Two latent trajectories were identified: a mild and remitting motor symptoms class (Class 1, 33.01%) and a severe and progressive motor symptom class (Class 2, 66.99%). Patients in Class 2 initially exhibited severe motor symptoms that worsened progressively despite receiving anti-PD medications. In comparison, patients in Class 1 exhibited milder symptoms that improved following drug therapy and a slower progression. During a 5-year follow-up, patients in Class 2 showed a higher risk of developing MCI compared to those in Class 1 before PSM (Log-Rank 28.58, p < 0.001) and after PSM (Log-Rank 8.20, p = 0.004).
PD patients with severe and progressive motor symptoms are more likely to develop MCI than those with mild and stable motor symptoms.
鲜有研究调查帕金森病(PD)患者运动进展异质性与早期认知障碍风险之间的关系。本研究旨在确定运动进展的不同轨迹并探讨其对预测轻度认知障碍(MCI)的影响。
从帕金森进展标志物倡议中收集了一个包括 415 名基线 PD 患者的 5 年队列。运动症状的严重程度使用运动障碍协会统一帕金森病评定量表第 III 部分进行评估。使用潜在类别轨迹模型和非线性混合效应模型分析和描绘运动症状的纵向变化。使用倾向评分匹配(PSM)最小化潜在混杂因素的影响。应用 Cox 比例风险模型计算 MCI 的风险比,并使用随访期间 MCI 的发生作为事件时间生成 Kaplan-Meier 曲线。
确定了两种潜在轨迹:轻度和缓解的运动症状类(Class 1,33.01%)和严重和进展性运动症状类(Class 2,66.99%)。Class 2 中的患者最初表现出严重的运动症状,尽管接受了抗 PD 药物治疗,但病情仍逐渐恶化。相比之下,Class 1 中的患者表现出较轻的症状,药物治疗后症状改善,进展较慢。在 5 年随访期间,未经 PSM 调整时,Class 2 患者发生 MCI 的风险高于 Class 1 患者(Log-Rank 28.58,p<0.001),经 PSM 调整后也高于 Class 1 患者(Log-Rank 8.20,p=0.004)。
与运动症状轻度且稳定的 PD 患者相比,运动症状严重且进展的 PD 患者更易发生 MCI。